The increasing mortality of idiopathic pulmonary fibrosis: fact or fallacy?

Christopher J Ryerson^{1

2}, Martin Kolb³

Affiliations

¹ Centre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, Canada chris.ryerson@hli.ubc.ca.
² Dept of Medicine, University of British Columbia, Vancouver, Canada.
³ Dept of Medicine, McMaster University, Hamilton, Canada.

Free article

Editorial

Christopher J Ryerson et al. Eur Respir J. 2018.

Free article

. 2018 Jan 18;51(1):1702420.

doi: 10.1183/13993003.02420-2017. Print 2018 Jan.

Christopher J Ryerson^{1

2}, Martin Kolb³

¹ Centre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, Canada chris.ryerson@hli.ubc.ca.
² Dept of Medicine, University of British Columbia, Vancouver, Canada.
³ Dept of Medicine, McMaster University, Hamilton, Canada.

No abstract available

Conflict of interest statement

Conflict of interest: Disclosures can be found alongside this article at erj.ersjournals.com

Trends in mortality from idiopathic pulmonary fibrosis in the European Union: an observational study of the WHO mortality database from 2001-2013.
Marshall DC, Salciccioli JD, Shea BS, Akuthota P. Marshall DC, et al. Eur Respir J. 2018 Jan 18;51(1):1701603. doi: 10.1183/13993003.01603-2017. Print 2018 Jan. Eur Respir J. 2018. PMID: 29348182